659 860
[4]
Carter BS, Bova GS, Beaty TH, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797–802.
[5]
Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371–4.[6]
Ewing CM, Ray AM, Lange EM, et al. Germline mutations in HOXB13 and prostate cancer risk. N Engl J Med 2012;366:141–9.[7]
Castro E, Goh C, Olmos D, , et al. Germline BRCA. mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol 2013;31:1748–57.[8]
Pritchard CC, Mateo J, Walsh MF, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med 2016;375:443–53.[9]
Na R, Zheng SL, Han M, et al. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death. Eur Urol 2017;71:740–7.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 5 7 – 6 5 9
659